LatestOpinion: The science on relieving cancer symptoms is clear. Why isn't insurance paying?
Cannabis

Cannabis Prices Vary Dramatically Across States: $15 in Washington vs $52 in Kentucky

High Times Contributors
Cannabis Prices Vary Dramatically Across States: $15 in Washington vs $52 in Kentucky
Summary

Cannabis prices fluctuate wildly across US states, with an eighth costing $15 in Washington but $52 in Kentucky, according to High Times' price index analysis. Former Massachusetts cannabis regulator Shawn Collins explains that strict state licensing caps and fragmented supply chains force each jurisdiction to rebuild entire distribution networks from scratch, unlike federally-regulated products such as bourbon. These regulatory barriers significantly impact patient access and affordability, particularly affecting medical marijuana patients in states with limited licenses and higher costs. Understanding these price disparities is crucial for patients seeking cost-effective treatment options and advocates pushing for regulatory reform.

HIGH TIMES

Originally published on

High Times

By High Times Contributors

Read full article(opens in new tab)

Fetched: September 22, 2026 at 10:02 AM

More news you might be interested in

View all
Brazilian Supreme Court Upholds Medical Cannabis Cultivation Right for Patient
Cannabis

Brazilian Supreme Court Upholds Medical Cannabis Cultivation Right for Patient

A Brazilian Supreme Court justice has maintained a legal protection (salvoconducto) allowing a patient to cultivate cannabis for medical purposes. Justice Alexandre de Moraes, Vice President of Brazil's Federal Supreme Court (STF), issued the ruling and warned that police interference with this judicial protection could constitute abuse of authority. This decision reinforces the legal framework protecting patients' rights to medical cannabis access in Brazil, where therapeutic use has gained increasing recognition. The ruling emphasizes judicial accountability and the importance of respecting court-ordered protections for patients utilizing cannabis-based treatments.

yesterday
Revista Cáñamo
Mexican Supreme Court Permits Cannabis-Infused Foods for Personal Use
Cannabis

Mexican Supreme Court Permits Cannabis-Infused Foods for Personal Use

Mexico's Supreme Court ruled that recreational cannabis self-consumption permits can legally include preparation of cannabis-infused foods for personal use, while explicitly prohibiting any sales, distribution, or transfer to third parties. This landmark decision clarifies the scope of personal cannabis use rights in Mexico, distinguishing between lawful individual consumption and illegal commercial activities. The ruling establishes that edible preparations fall within protected personal use categories, similar to smoking or vaporizing. This development has implications for cannabis policy discussions across Latin America and provides clearer guidance for Mexican citizens regarding legal preparation and consumption methods.

yesterday
Revista Cáñamo
MJBizDaily
Cannabis

Virginia Cannabis Regulators Plan License Lottery, Set Cultivation Limits

Virginia's cannabis regulators have unveiled draft adult-use rules featuring a lottery system for retail licenses instead of the previously planned 350 licenses, along with cultivation limits and fee structures for operators. The regulatory framework represents a significant shift in how the state will distribute cannabis business licenses, aiming to ensure fair market access for entrepreneurs. These rules are crucial for patients and operators to understand as Virginia continues developing its legal adult-use cannabis market. The lottery system may affect product availability, pricing, and access to cannabis for both medical and recreational consumers throughout the state.

yesterday
MJBizDaily
Cheaper Flower, More Choice, No Surge in Use: The Netherlands' Cannabis Pilot Delivers Its First Results
Cannabis

Cheaper Flower, More Choice, No Surge in Use: The Netherlands' Cannabis Pilot Delivers Its First Results

The Netherlands' regulated cannabis pilot program is reshaping market dynamics by expanding product variety and reducing flower prices on coffeeshop shelves. Early findings reveal that despite increased accessibility and affordability, consumption rates, health outcomes, and public safety metrics have remained relatively stable. The pilot demonstrates that regulated legalization can improve consumer choice and affordability without necessarily driving increased use or adverse public health effects. However, the illicit cannabis market has not disappeared, suggesting that regulation alone may require complementary enforcement strategies. These results provide valuable insights for other jurisdictions considering medical cannabis legalization and regulatory frameworks.

yesterday
High Times